Journal
APPLIED RADIATION AND ISOTOPES
Volume 88, Issue -, Pages 32-37Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.apradiso.2014.01.014
Keywords
Boron neutron capture therapy; Hepatocellular carcinoma; Water-in-oil-in-water emulsion; Intra-arterial injection
Categories
Funding
- Ministry of Education, Science and Culture of Japan [18390360, 24390311]
- Kyushu Bureau of the Ministry of Economy, Trade and Industry of Japan [17G8009]
- Foundation of Kyushu Medical Resource in Japan
- Grants-in-Aid for Scientific Research [23300348, 24390311, 18390360] Funding Source: KAKEN
Ask authors/readers for more resources
A 63-year-old man with multiple HCC in his left liver lobe was enrolled as the first patient in a pilot study of boron neutron capture therapy (BNCT) involving the selective intra-arterial infusion of a (BSH)-B-10-containing water-in-oil-in-water emulsion ((BSH)-B-10-WOW). The size of the tumorous region remained stable during the 3 months after the BNCT. No adverse effects of the BNCT were observed. The present results show that (BSH)-B-10-WOW can be used as novel intra-arterial boron carriers during BNCT for HCC. (C) 2014 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
